Salvage chemoradiotherapy after primary chemotherapy for locally advanced pancreatic cancer: a single-institution retrospective analysisHiroshi Mayahara, Jun Itami, Yoshinori Ito et al.|BMC Cancer|2012Cited by 12
Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patientsChigusa Morizane, Tomohiro Yamaguchi, Masafumi Ikeda et al.|Cancer Chemotherapy and Pharmacology|2011Cited by 8